Welcome to Molecular Psychiatry

Molecular Psychiatry publishes papers elucidating the biological mechanisms underlying psychiatric disorders and their treatment. The emphasis is on studies at the interface of pre-clinical and clinical research, including studies at the cellular, molecular, integrative, clinical, imaging and psychopharmacology levels.


ALSO FROM NATURE PUBLISHING GROUP: Translational Psychiatry
Editor-in-Chief: Julio Licinio, MD; Impact Factor 4.730*

Translational Psychiatry, a sister journal to Molecular Psychiatry, is an online-only, open access publication that provides high quality research, a respected editorial team, rapid publication and high visibility. Visit http://www.nature.com/tp.

 

Check out the joint Molecular Psychiatry and Translational Psychiatry web focus, which features all articles authored by Nobel Laureates in these two journals! 


About the cover

Volume 22, No 8
August 2017

ISSN: 1359-4184
EISSN: 1476-5578

2016 Impact Factor 13.204*
4/142 Psychiatry
8/258 Neurosciences
7/286 Biochemistry & Molecular Biology

Editor:
Julio Licinio, MD

*2016 Journal Citation Reports® Science Edition (Clarivate Analytics, 2017)

NEWS

Check out Molecular Psychiatry's recently published paper on stress-induced depression, co-authored by Nobel Laureate Paul Greengard!

Molecular Psychiatry was mentioned: A study published in Molecular Psychiatry provides evidence that children with lower socioeconomic status are more prone to mental illness. This study could with the development of strategies and personalized treatment for mental illness. Read the article or the news story!

An Immediate Communication in Molecular Psychiatry reports a molecular mechanism whereby NMDA receptor antagonists such as ketamine can increase mTOR signaling to elicit antidepressant actions. Drugs selectively targeting components of this pathway may offer novel approaches to the treatments of depression. Read the report now.

Molecular Psychiatry is now a member of the Neuroscience Peer Review Consortium (NPRC). The purpose of the NPRC is to decrease the time and effort involved in the peer review process, and reduce the burden placed on reviewers. NPRC member journals agree to transfer manuscript reviews upon the author's request. A flowchart of the transfer process and a list of member journals can be found on the NPRC website.

Visit Nature Publishing Group's open access funding page for information about research funders and institutions that provide funding for open access. NPG also offers an APC support service to make it easier for NPG authors to discover and apply for open access funding. For advice on what funding is available to you and help in approaching funders and institutions, please contact us at openaccess@nature.com.

Want to order a poster of a Molecular Psychiatry journal cover? If so, follow this link to the order form.

TOP TEN MOST VIEWED PAPERS


The Top Ten charts the articles that have been downloaded most often over the previous 30 days, in HTML and PDF format, from the Molecular Psychiatry website. The chart does not rank the quality, scientific significance or citation impact of the content. However, it may bring articles to your attention that you might not have otherwise noticed. We hope you enjoy them.


July 2017

  1. A genome-wide association study for extremely high intelligence

    D Zabaneh, E Krapohl, H A Gaspar, C Curtis, S H Lee, H Patel, S Newhouse, H M Wu, M A Simpson, M Putallaz, D Lubinski, R Plomin & G Breen

    doi:10.1038/mp.2017.121

    Abstract | Full Text | PDF

  2. Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood

    N Dedic, M L Pöhlmann, J S Richter, D Mehta, D Czamara, M W Metzger, J Dine, B T Bedenk, J Hartmann, K V Wagner, A Jurik, L M Almli, A Lori, S Moosmang, F Hofmann, C T Wotjak, G Rammes, M Eder, A Chen, K J Ressler, W Wurst, M V Schmidt, E B Binder & J M Deussing

    doi:10.1038/mp.2017.133

    Abstract | Full Text | PDF

  3. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways

    G B Rogers, D J Keating, R L Young, M-L Wong, J Licinio & S Wesselingh

    doi:10.1038/mp.2016.50

    Abstract | Full Text | PDF

  4. Prenatal fever and autism risk

    M Hornig, M A Bresnahan, X Che, A F Schultz, J E Ukaigwe, M L Eddy, D Hirtz, N Gunnes, K K Lie, P Magnus, S Mjaaland, T Reichborn-Kjennerud, S Schjølberg, A-S Øyen, B Levin, E S Susser, C Stoltenberg & W I Lipkin

    doi:10.1038/mp.2017.119

    Abstract | Full Text | PDF

  5. Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease

    M A Lalli, B M Bettcher, M L Arcila, G Garcia, C Guzman, L Madrigal, L Ramirez, J Acosta-Uribe, A Baena, K J Wojta, G Coppola, R Fitch, M D de Both, M J Huentelman, E M Reiman, M E Brunkow, G Glusman, J C Roach, A W Kao, F Lopera & K S Kosik

    doi:10.1038/mp.2015.131

    Abstract | Full Text | PDF

  6. FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system

    K Yalla, C Elliott, J P Day, J Findlay, S Barratt, Z A Hughes, L Wilson, E Whiteley, M Popiolek, Y Li, J Dunlop, R Killick, D R Adams, N J Brandon, M D Houslay, B Hao & G S Baillie

    doi:10.1038/mp.2017.138

    Abstract | Full Text | PDF

  7. Toward fine-grained phenotyping of suicidal behavior: the role of suicidal subtypes

    J A Bernanke, B H Stanley & M A Oquendo

    doi:10.1038/mp.2017.123

    Abstract | Full Text | PDF

  8. Neuronal plasticity and neurotrophic factors in drug responses

    E Castrén & H Antila

    doi:10.1038/mp.2017.61

    Abstract | Full Text | PDF

  9. Genome-wide meta-analysis of cognitive empathy: heritability, and correlates with sex, neuropsychiatric conditions and cognition

    V Warrier, K L Grasby, F Uzefovsky, R Toro, P Smith, B Chakrabarti, J Khadake, E Mawbey-Adamson, N Litterman, J-J Hottenga, G Lubke, D I Boomsma, N G Martin, P K Hatemi, S E Medland, D A Hinds, T Bourgeron & S Baron-Cohen

    doi:10.1038/mp.2017.122

    Abstract | Full Text | PDF

  10. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial

    R E Frye, J Slattery, L Delhey, B Furgerson, T Strickland, M Tippett, A Sailey, R Wynne, S Rose, S Melnyk, S Jill James, J M Sequeira & E V Quadros

    doi:10.1038/mp.2016.168

    Abstract | Full Text | PDF